From: miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma
Parameters | miR-589-5pLow | miR-589-5pHigh | p Value | |
---|---|---|---|---|
Male/Female | Â | 15/4 | 20/1 | 0.281 |
Age* | Â | 50 (32-65) | 48 (32-61) | 0.849 |
HBsAg | Â | Â | Â | Â |
 | Positive | 15 (78.9 %) | 20 (95.2 %) | 0.281 |
 | Negative | 4 (21.1) | 1 (4.8 %) | |
AFP | Â | Â | Â | Â |
 | Normal | 9 (47.4 %) | 12 (57.1 %) | 0.536 |
 | High | 10 (52.6 %) | 9 (42.9 %) | |
Vascular Invasion | Â | Â | Â | Â |
 | Positive | 7 (36.8 %) | 1 (4.8 %) | 0.033 |
 | Negative | 12 (63.2 %) | 20 (95.2 %) | |
Tumer Size(cm)* | Â | 7 (4-16) | 5.5 (2.5-15) | 0.254 |
Recurrence | Â | 18 (94.7Â %) | 10 (47.6Â %) | 0.001 |
Edmondson Grade | I/II | 10 (52.6Â %) | 17 (81.0Â %) | 0.056 |
 | III/IV | 9 (47.4 %) | 4 (19.0 %) |